A 6-Month, Open-Label, Extension Study of the Tolerability and Effectiveness of the Methylphenidate Transdermal System in Adolescents Diagnosed with Attention-Deficit/Hyperactivity Disorder-Reference-Cited by-同舟云学术

A 6-Month, Open-Label, Extension Study of the Tolerability and Effectiveness of the Methylphenidate Transdermal System in Adolescents Diagnosed with Attention-Deficit/Hyperactivity Disorder

Published:2010-10 Issue:5 Volume:20 Page:365-375
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Findling Robert L.¹,Katic Alain²,Rubin Richard³,Moon Eliot⁴,Civil Richard⁵,Li Yunfeng⁵

Affiliation:

1. University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio.

2. Claghorn Lesem Research Clinic Ltd., Houston, Texas.

3. The Vermont Clinical Center and Dartmouth Medical College, Burlington, Vermont.

4. Elite Clinical Trials, Inc., Temecula, California.

5. Shire Development, Inc., Wayne, Pennsylvania. Dr. Li is now at Cereta, Inc., Oakland, California.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology, and Child Health

Link

http://www.liebertpub.com/doi/pdf/10.1089/cap.2009.0122

Reference34 articles.

1. Quality of Life Assessment in Adult Patients With Attention-deficit/Hyperactivity Disorder Treated With Atomoxetine

2. Review of Medication Adherence in Children and Adults with ADHD

3. Indication and Use of Drug Products Used to Treat Attention-Deficit/Hyperactivity Disorder: A Cross-Sectional Study with Inference on the Likelihood of Treatment in Adulthood

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD);Cochrane Database of Systematic Reviews;2023-03-27

2. Cardiovascular Considerations for Stimulant Class Medications;Child and Adolescent Psychiatric Clinics of North America;2022-07

3. Systematic review of transdermal treatment options in attention-deficit/hyperactivity disorder: implications for use in adult patients;CNS Spectrums;2021-04-12

4. Evaluation of Methylphenidate Safety and Maximum-Dose Titration Rationale in Attention-Deficit/Hyperactivity Disorder;JAMA Pediatrics;2019-07-01

5. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies;Cochrane Database of Systematic Reviews;2018-05-10